SR ONE CAPITAL MANAGEMENT, LP Q1 2024 Filing
Filed May 13, 2024
Portfolio Value
$364.1B
Holdings
6
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (6 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACLXARCELLX INC | 2,346,630 | $163.2B | 44.83% | |
| 2 | CRSPCRISPR THERAPEUTICS AG | 1,048,951 | $71.5B | 19.64% | |
| 3 | SPRYARS PHARMACEUTICALS INC | 4,012,903 | $41.0B | 11.26% | |
| 4 | NKTXNKARTA INC | 3,333,333 | $36.0B | 9.90% | |
| 5 | DSGNDESIGN THERAPEUTICS INC | 6,526,476 | $26.3B | 7.22% | |
| 6 | MLYSMINERALYS THERAPEUTICS INC | 2,016,822 | $26.0B | 7.15% |